Reyna-Villasmil E, Torres-Cepeda D, Pea-Paredes E, Meja-Montill J, Reyna-Villasmil N, Gonzlez-Rodrguez P
in: PubMed | Google Scholar | 1 Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
Mounjaro may cause serious side effects, including: Inflammation of the pancreas (pancreatitis)
1998, Leinonen et al
however, only 5% of death certificates listed dementia as the underlying cause of death for this age group, suggesting underreporting on death certificates
(3) Clinical Validation: Large-scale, well-designed clinical trials are urgently needed to evaluate the safety and efficacy of ferroptosis-targeting strategies (e.g., deferiprone, novel inhibitors) in COPD patients, ideally using biomarker-driven patient selection (e.g., based on MDA, 4-HNE, or GPX4 activity levels)